Clinical trials
Phase 1/2 Melanoma trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 9 |
| Unknown status | 3 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 4 |
| Universitair Ziekenhuis Brussel | 3 |
| Ludwig Institute for Cancer Research | 2 |
| Novartis Pharmaceuticals | 2 |
| Aprea Therapeutics | 1 |
| BBB-Therapeutics B.V. | 1 |
| BioNTech SE | 1 |
| Bristol-Myers Squibb | 1 |
| Daiichi Sankyo | 1 |
| Genmab | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 24 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Neoplasm Metastasis | 6 |
| Triple Negative Breast Neoplasms | 5 |
| Carcinoma, Renal Cell | 4 |
| Carcinoma, Transitional Cell | 4 |
| Colorectal Neoplasms | 4 |
| Endometrial Neoplasms | 4 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Carcinoma, Hepatocellular | 3 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.